Which medications are used in adjuvant therapy for HER2-positive breast cancer?

Updated: Jul 16, 2020
  • Author: Maurie Markman, MD, MS; Chief Editor: Karl S Roth, MD  more...
  • Print
Answer

Answer

HER2 agents used in adjuvant therapy for HER2-positive breast cancer include the following:

  • Trastuzumab
  • Neratinib, extended adjuvant therapy following trastuzumab-based therapy
  • Lapatinib, particularly in combination with capecitabine
  • Pertuzumab
  • Trastuzumab/pertuzumab/hyaluronidase

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!